Atlas Venture closes USD250m Opportunity Fund
Atlas Venture, a venture capital firm investing in breakthrough biotech innovation, has closed its first Opportunity Fund, raising USD250 million in an oversubscribed fundraise. With Atlas Venture Opportunity Fund I (AVOF I), the firm will invest in existing Atlas portfolio companies as they progress. “We are delighted and humbled by
